基因疗法先驱创办,iECURE A轮总融资超1亿美元,拟2023年推进临床试验
近日,由基因疗法先驱 Jim Wilson 创立的生物技术公司 iECURE 宣布完成了 6500 万美元的 A 系列延期融资 ,以将其用于治疗鸟氨酸转氨甲酰酶缺乏症的候选药物推进临床。
【资料图】
本轮由 NovoHoldings 和 LYFECapital 共同领投,Versant OrbiMe 跟投。2021 年 9 月, iECURE 筹集了由后两者领投的 5000 万美元 A 轮融资。新的资金将使 iECURE 通过初步的人体试验。但在此之前,首席执行官 Joe Truitt 称会先计划将其员工人数增加一倍,目前有 12 名全职成员,包括聘请一名 CMO,为临床试验做准备。
iECURE 源于 “肝脏” 的拉丁文 “iecur”,“我们在词尾添加了 e,意味着治愈。” Joseph Truitt 表示。自 iECURE 成立后,Truitt 就被聘请担任 CEO,此前,他在 Achillion Pharmaceuticals(已被收购)工作 11 年,曾担任 CEO。
宾夕法尼亚大学和 Wilson 共同持有 iECURE 的股份。根据 iECURE 与宾夕法尼亚大学的协议,Wilson 实验室将对 iECURE 选定的管线进行临床前研究和制造,以及毒理实验,进入新药申请阶段时,将由 iECURE 接管并进行临床开发,如果获得批准,将进行商业化。
此外, Precision Bio 也获得了 iECURE 的部分股份。该公司已经 iECURE 达成合作开发同种异体 CAR-T 和体内基因疗法。
事实上, Wilson 和 Precision Bio 早有合作。过去 5 年,Wilson 和他的团队一直在研究生物体内对肝细胞基因组进行切割,然后插入正常的基因的相关机制。自从 80 年代后期他在实验室担任博士后以来,Wilson 就认为 肝脏是基因治疗的一个重要目标。 “因为很多疾病的根源都在肝脏。”Wilson 曾表示。
▲ 图 | iECURE 研发进展(来源:公司官网)
Wilson 及团队尝试了包括 CRISPR 在内的各种基因编辑工具,但收效甚微,直到使用 Precision Bio 的技术。这家位于北卡罗莱纳州的生物技术公司开发了一种名为 ARCUS 的平台。
ARCUS 是一个独特的、专有的、多功能的基因组编辑平台,其属性包括特异性、进行各种有效编辑(敲入、敲除和修复)的能力,从而实现一系列治疗性编辑。该平台基于一种称为 I-CreI 的天然基因组编辑酶,该酶从衣藻中进化而来,是一种归巢核酸内切酶,可以在细胞 DNA 中进行高强度特异性切割。
归巢核酸内切酶是一种非常罕见的内切酶,它们可以识别的 DNA 序列比经典的限制酶识别的范围要大。与基因编辑研究中的其它酶相比,I-CreI 酶仅有 364 个氨基酸,可用于插入、删除或者编辑 DNA。这也意味着,I-CreI 酶更容易被 AAV 递送。
此次将推进临床的鸟氨酸氨甲酰基转移酶缺乏会导致血液中氨浓度升高,婴儿通常会在出生后几天内出现症状。对于临床试验,治疗必须在非常小的时候进行——不到 8 个月。出于这个原因, iECURE 的非人类灵长类动物测试是在新生灵长类动物身上进行,以应对必须在非常小的年龄的患者上进行治疗这一事实。
合作开发同种异体 CAR-T 和体内基因疗法。"}}},"align":"","folded":false}},"LqQydw4Cwoc2ikxGWa7c2V7DnEd":{"id":"LqQydw4Cwoc2ikxGWa7c2V7DnEd","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"Pq6UdAUm2oA0E4x21TucwFm6nVd":{"id":"Pq6UdAUm2oA0E4x21TucwFm6nVd","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["author","6980198808172969986"],"1":["bold","true"]}},"initialAttributedTexts":{"attribs":{"0":"*0+3c*0*1+e*0+s"},"text":{"0":"事实上,Wilson 和 Precision Bio 早有合作。过去 5 年,Wilson 和他的团队一直在研究生物体内对肝细胞基因组进行切割,然后插入正常的基因的相关机制。自从 80 年代后期他在实验室担任博士后以来,Wilson 就认为肝脏是基因治疗的一个重要目标。“因为很多疾病的根源都在肝脏。”Wilson 曾表示。"}}},"align":"","folded":false}},"Se8wdsCUWoKeqsxue9mcfQ2knhh":{"id":"Se8wdsCUWoKeqsxue9mcfQ2knhh","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"LswWdGyYuo6CUGx6av8ceFNtnMf":{"id":"LswWdGyYuo6CUGx6av8ceFNtnMf","snapshot":{"type":"image","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","align":"center","image":{"token":"boxcneo3Vsb7DnYxgYZw0hcydMh","mimeType":"image/png","size":451047,"scale":1,"width":2037,"height":838,"name":"4014edf2a4a099053784296198ff663.png"}}},"R60Ed8MueoomQExCufvcdnywnOf":{"id":"R60Ed8MueoomQExCufvcdnywnOf","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6980198808172969986"]}},"initialAttributedTexts":{"attribs":{"0":"*0+n"},"text":{"0":"图 | iECURE研发进展(来源:公司官网)"}}},"align":"","folded":false}},"TU0eduy4koKuIqxEJ4YcCFtvnMb":{"id":"TU0eduy4koKuIqxEJ4YcCFtvnMb","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6980198808172969986"]}},"initialAttributedTexts":{"attribs":{"0":"*0|1+1*0+2r"},"text":{"0":"nWilson 及团队尝试了包括 CRISPR 在内的各种基因编辑工具,但收效甚微,直到使用 Precision Bio 的技术。这家位于北卡罗莱纳州的生物技术公司开发了一种名为 ARCUS 的平台。"}}},"align":"","folded":false}},"XK4GdiA2eoUSUax6C5Fcx7rUngg":{"id":"XK4GdiA2eoUSUax6C5Fcx7rUngg","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"LMs0dgEIqo6CKsxqnD2ch4Crndb":{"id":"LMs0dgEIqo6CKsxqnD2ch4Crndb","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6980198808172969986"]}},"initialAttributedTexts":{"attribs":{"0":"*0+40"},"text":{"0":"ARCUS 是一个独特的、专有的、多功能的基因组编辑平台,其属性包括特异性、进行各种有效编辑(敲入、敲除和修复)的能力,从而实现一系列治疗性编辑。该平台基于一种称为 I-CreI 的天然基因组编辑酶,该酶从衣藻中进化而来,是一种归巢核酸内切酶,可以在细胞 DNA 中进行高强度特异性切割。"}}},"align":"","folded":false}},"FGOmdOc2IoAQg6xuseEcTLa8ncd":{"id":"FGOmdOc2IoAQg6xuseEcTLa8ncd","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"X8wUd2A8CokWwsxOS2ucAmEXnif":{"id":"X8wUd2A8CokWwsxOS2ucAmEXnif","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6980198808172969986"]}},"initialAttributedTexts":{"attribs":{"0":"*0+3i"},"text":{"0":"归巢核酸内切酶是一种非常罕见的内切酶,它们可以识别的 DNA 序列比经典的限制酶识别的范围要大。与基因编辑研究中的其它酶相比,I-CreI 酶仅有 364 个氨基酸,可用于插入、删除或者编辑 DNA。这也意味着,I-CreI 酶更容易被 AAV 递送。"}}},"align":"","folded":false}},"EmMkdm0cWoyKucxY9EccCsNDn5c":{"id":"EmMkdm0cWoyKucxY9EccCsNDn5c","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"KqU0d6ecuoqOMIxyUZ3cWljkn6b":{"id":"KqU0d6ecuoqOMIxyUZ3cWljkn6b","snapshot":{"type":"text","parent_id":"Q9qPdvsCMot90ZxLEbicL25mnWg","comments":[],"locked":false,"hidden":false,"author":"6980198808172969986","children":[],"text":{"initialAttributedTexts":{"text":{"0":"此次将推进临床的鸟氨酸氨甲酰基转移酶缺乏会导致血液中氨浓度升高,婴儿通常会在出生后几天内出现症状。对于临床试验,治疗必须在非常小的时候进行——不到 8 个月。出于这个原因,iECURE 的非人类灵长类动物测试是在新生灵长类动物身上进行,以应对必须在非常小的年龄的患者上进行治疗这一事实。"},"attribs":{"0":"*0+3z"}},"apool":{"numToAttrib":{"0":["author","6980198808172969986"]},"nextNum":1}},"align":"","folded":false}},"Q9qPdvsCMot90ZxLEbicL25mnWg":{"id":"Q9qPdvsCMot90ZxLEbicL25mnWg","snapshot":{"type":"page","parent_id":"","comments":null,"locked":false,"hidden":false,"author":"6980198808172969986","children":["EuUodiaG6oa8q6xoDJ8cqEBOnWe","ZKM8d8UCIoGogixU9xPc0k6inCe","PEuGdWGyComUKkxIrYIcFY2JnOe","Z6UKd6Qa6ogUWixk9IacDbcMn6c","YQgWdMIQEogY60x8CYAcWjwynHc","AIwsdMiYgoW6iQxs1WWcLoQbnGe","V2Wwd4SM0oCWqGxy44RcWBbjnSR","UA8uduGgqoo8KcximYPc1fYZn9g","Ok6OduCc8ouWyoxOGcOcHFIPnog","LSEYdAqsOoSAuix6ZaKclDB3nkb","Wgs8dscU2oIwg2xsjs3cBYfYnCf","L8oyd0ISmoI8aUxiMZFc4xn4nMh","W0iSd0ckuo0uuexcbcdcpHhVntf","S6WEd2ekmoIqOcxchdWc2sHDnvf","LqQydw4Cwoc2ikxGWa7c2V7DnEd","Pq6UdAUm2oA0E4x21TucwFm6nVd","Se8wdsCUWoKeqsxue9mcfQ2knhh","LswWdGyYuo6CUGx6av8ceFNtnMf","R60Ed8MueoomQExCufvcdnywnOf","TU0eduy4koKuIqxEJ4YcCFtvnMb","XK4GdiA2eoUSUax6C5Fcx7rUngg","LMs0dgEIqo6CKsxqnD2ch4Crndb","FGOmdOc2IoAQg6xuseEcTLa8ncd","X8wUd2A8CokWwsxOS2ucAmEXnif","EmMkdm0cWoyKucxY9EccCsNDn5c","KqU0d6ecuoqOMIxyUZ3cWljkn6b","Hgc4dUACuo6W68xm4nOc1mWjnBc","CQEQd4wqCoMkwoxCm7Nclmo7nue","NIocde06qoaiq2xIr2Rces5Dnxg","Zgyid4IGaocgSCxGwxucq3Qsn0f"],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6980198808172969986"]}},"initialAttributedTexts":{"attribs":{"0":"*0+13"},"text":{"0":"基因疗法先驱创办,iECURE A轮总融资超1亿美元,拟2023年推进临床试验"}}},"align":""}}},"payloadMap":{"V2Wwd4SM0oCWqGxy44RcWBbjnSR":{"level":1},"UA8uduGgqoo8KcximYPc1fYZn9g":{"level":1},"Ok6OduCc8ouWyoxOGcOcHFIPnog":{"level":1},"LSEYdAqsOoSAuix6ZaKclDB3nkb":{"level":1},"Wgs8dscU2oIwg2xsjs3cBYfYnCf":{"level":1},"L8oyd0ISmoI8aUxiMZFc4xn4nMh":{"level":1},"W0iSd0ckuo0uuexcbcdcpHhVntf":{"level":1},"S6WEd2ekmoIqOcxchdWc2sHDnvf":{"level":1},"LqQydw4Cwoc2ikxGWa7c2V7DnEd":{"level":1},"Pq6UdAUm2oA0E4x21TucwFm6nVd":{"level":1},"Se8wdsCUWoKeqsxue9mcfQ2knhh":{"level":1},"R60Ed8MueoomQExCufvcdnywnOf":{"level":1},"TU0eduy4koKuIqxEJ4YcCFtvnMb":{"level":1},"XK4GdiA2eoUSUax6C5Fcx7rUngg":{"level":1},"LMs0dgEIqo6CKsxqnD2ch4Crndb":{"level":1},"FGOmdOc2IoAQg6xuseEcTLa8ncd":{"level":1},"X8wUd2A8CokWwsxOS2ucAmEXnif":{"level":1},"EmMkdm0cWoyKucxY9EccCsNDn5c":{"level":1},"KqU0d6ecuoqOMIxyUZ3cWljkn6b":{"level":1}},"extra":{"mention_page_title":{},"external_mention_url":{}},"isKeepQuoteContainer":false,"selection":[{"id":8,"type":"text","selection":{"start":0,"end":92},"recordId":"V2Wwd4SM0oCWqGxy44RcWBbjnSR"},{"id":9,"type":"text","selection":{"start":0,"end":0},"recordId":"UA8uduGgqoo8KcximYPc1fYZn9g"},{"id":10,"type":"text","selection":{"start":0,"end":192},"recordId":"Ok6OduCc8ouWyoxOGcOcHFIPnog"},{"id":11,"type":"text","selection":{"start":0,"end":0},"recordId":"LSEYdAqsOoSAuix6ZaKclDB3nkb"},{"id":12,"type":"text","selection":{"start":0,"end":149},"recordId":"Wgs8dscU2oIwg2xsjs3cBYfYnCf"},{"id":13,"type":"text","selection":{"start":0,"end":142},"recordId":"L8oyd0ISmoI8aUxiMZFc4xn4nMh"},{"id":14,"type":"text","selection":{"start":0,"end":0},"recordId":"W0iSd0ckuo0uuexcbcdcpHhVntf"},{"id":15,"type":"text","selection":{"start":0,"end":73},"recordId":"S6WEd2ekmoIqOcxchdWc2sHDnvf"},{"id":16,"type":"text","selection":{"start":0,"end":0},"recordId":"LqQydw4Cwoc2ikxGWa7c2V7DnEd"},{"id":17,"type":"text","selection":{"start":0,"end":162},"recordId":"Pq6UdAUm2oA0E4x21TucwFm6nVd"},{"id":18,"type":"text","selection":{"start":0,"end":0},"recordId":"Se8wdsCUWoKeqsxue9mcfQ2knhh"},{"id":19,"type":"block","recordId":"LswWdGyYuo6CUGx6av8ceFNtnMf"},{"id":20,"type":"text","selection":{"start":0,"end":23},"recordId":"R60Ed8MueoomQExCufvcdnywnOf"},{"id":21,"type":"text","selection":{"start":0,"end":100},"recordId":"TU0eduy4koKuIqxEJ4YcCFtvnMb"},{"id":22,"type":"text","selection":{"start":0,"end":0},"recordId":"XK4GdiA2eoUSUax6C5Fcx7rUngg"},{"id":23,"type":"text","selection":{"start":0,"end":144},"recordId":"LMs0dgEIqo6CKsxqnD2ch4Crndb"},{"id":24,"type":"text","selection":{"start":0,"end":0},"recordId":"FGOmdOc2IoAQg6xuseEcTLa8ncd"},{"id":25,"type":"text","selection":{"start":0,"end":126},"recordId":"X8wUd2A8CokWwsxOS2ucAmEXnif"},{"id":26,"type":"text","selection":{"start":0,"end":0},"recordId":"EmMkdm0cWoyKucxY9EccCsNDn5c"},{"id":27,"type":"text","selection":{"start":0,"end":143},"recordId":"KqU0d6ecuoqOMIxyUZ3cWljkn6b"}],"pasteFlag":"c102478c-3f11-46d6-b4bb-a0e1066e18e4"}" data-lark-record-format="docx/record">
相关阅读
-
基因疗法先驱创办,iECURE A轮总融资超...
近日,由基因疗法先驱JimWilson创立的生物技术公司iECURE宣布完成了 -
环球快消息!2022年12月6日周二北京限行...
➤2022年12月6日周二北京限行尾号是几和几?答:2和7。➤外省、区、... -
全国首个超高清视频产业发展白皮书在蓉...
12月1日,在由四川省超高清视频产业联盟、电子信息产业发展研究院电... -
幸福成都 美在文明|与法同行 践行文...
“作为成都文明公益大使,我们对全体成都市民作出庄严承诺:我们将... -
热门看点:养老保险公司商业养老金业务...
近日,银保监会发布通知,从2023年1月1日起开展养老保险公司商业养... -
微速讯:11月份国际航班量持续上行 平...
12月1日,“飞常准”披露数据称,11月份,国内航司的国际航线实际执... -
当前讯息:网售药品首批禁止清单出炉 ...
12月1日起,《药品网络销售监督管理办法》(以下简称《管理办法》)正... -
【当前独家】驾校培训存在多少“潜规则”?
调查动机近日,记者接到河北沧州的读者小李来电称,其在驾校培训时... -
世界微资讯!快递隐私面单日均使用超1.5亿
今年以来,很多消费者都反映收取快递时越来越安心:收件人的姓名、... -
环球微头条丨央行月末逆回购力度加大 ...
近日,中国人民银行逆回购操作力度逐渐加大,由上周的净回笼转变为... -
韩国流行“反向海淘” 中国筋膜枪、电...
中新网杭州12月1日电(梁穆)今年“反向海淘”在韩国火了!双十一和“... -
聚焦:商业养老金业务压轴面世,4家机构...
随着我国老龄化程度的不断加深,“养老的钱从哪儿来”已成为全社会... -
【环球播资讯】部分药品降价超90%!第七...
今年7月,第七批国家组织药品集采中标药品名单及价格公布,涉及31个... -
全球快报:四川教资面试报名照片有什么要求
四川教资面试报名照片有什么要求(1)本人近6个月以内的免冠、正面、... -
今头条!成都科学有序开展核酸检测 亮...
目前,我市在疫情防控中坚持国家防控方案第九版、落实二十条优化措... -
天天短讯!广州市职工医疗保险和生育保...
实施日期:2022年12月01日失效日期:2026年12月31日图源:广州市人... -
前沿热点:2022年12月1日起广州珠江公园...
广州珠江公园恢复开园通告尊敬的市民游客:广州珠江公园于2022年12... -
快报:深圳异地长期居住人员备案办理材料
异地长期居住人员备案办理材料:1、《深圳市常住异地就医备案登记表... -
天天精选!商业养老金业务试点落地:10...
继专属商业养老保险、养老理财产品、特定养老储蓄等试点后,商业养... -
银行股大面积“破净”,可转债发行热情不减
近期,市场上迎来第五家银行可转债。11月30日,齐鲁银行披露公开发...